Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milestone Scientific's revenue per share for the
three
months ended in Jun. 2026 was $0.03.
Milestone Scientific's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.11.
Warning Sign:
Milestone Scientific Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Milestone Scientific was -1.80% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -4.50% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 0.80% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was -14.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Milestone Scientific's Revenue per Share or its related term are showing as below:
MLSS'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -37.1 Med: -6.3 Max: 68.8
Current: -4.5
During the past 13 years, Milestone Scientific's highest 3-Year average Revenue Per Share Growth Rate was 68.80% per year. The lowest was -37.10% per year. And the median was -6.30% per year.
MLSS's 3-Year Revenue Growth Rate is ranked worse than 68.44% of 754
companies
in the Medical Devices & Instruments industry
Industry Median: 3.7
vs MLSS: -4.50
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Milestone Scientific Revenue per Share Related Terms
Milestone Scientific Revenue per Share Historical Data
* Premium members only.
The historical data trend for Milestone Scientific's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLSS vs NEPH, HBIO, POCI: Revenue per Share Comparison
For the Medical Instruments & Supplies subindustry, Milestone Scientific's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Scientific PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's PS Ratio distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's PS Ratio falls into.
Milestone Scientific Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Milestone Scientific's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific (MLSS) has a Revenue per Share of $0.11 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Milestone Scientific and its competitors. According to the industry distribution chart, Milestone Scientific ranks #516 out of 754 companies in the Medical Devices & Instruments industry, placing it in the top 68.4%.
Is Milestone Scientific's Revenue per Share too high?
Milestone Scientific's current Revenue per Share is $0.11. The Medical Devices & Instruments industry median Revenue per Share is 3.70. Milestone Scientific's value of $0.11 is 97% below this industry median. Based on the distribution chart, Milestone Scientific ranks #516 out of 754 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Milestone Scientific has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Milestone Scientific's Revenue per Share compare to NEPH and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Milestone Scientific ranks #516 out of 754 companies for Revenue per Share. This places Milestone Scientific in the lower half of its industry. The industry median Revenue per Share is 3.70. Milestone Scientific's value of $0.11 is 97% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.70, based on 754 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Scientific's current Revenue per Share of $0.11 is 97% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Milestone Scientific and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Scientific's current Revenue per Share is $0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Scientific stock overvalued right now?
Based on GuruFocus' analysis, Milestone Scientific (MLSS) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.60, compared to a current price of $0.50 — trading 17.5% below its estimated fair value. The current Revenue per Share is $0.11 and 97% below the Medical Devices & Instruments industry median of 3.70. Milestone Scientific's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Milestone Scientific (MLSS), the current Revenue per Share is $0.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milestone Scientific (MLSS) Overvalued in 2026?
Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued.
The current stock price of $0.50 is trading 17.5% below its estimated GF Value™ of $0.60.
GuruFocus considers Milestone Scientific to be Modestly Undervalued.
Key valuation signals for MLSS:
Revenue per Share: $0.11
GF Value™: $0.60 vs. price of $0.50 (17.5% below fair value)
Industry Position: 97% below the Medical Devices & Instruments median (#516 of 754)
No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
37GF Score
Get the complete analysis for MLSS
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLSS has been successfully added to your 
